Page last updated: 2024-09-04

docetaxel anhydrous and acetyl-11-ketoboswellic acid

docetaxel anhydrous has been researched along with acetyl-11-ketoboswellic acid in 2 studies

Compound Research Comparison

Studies (docetaxel anhydrous)	Trials (docetaxel anhydrous)	Recent Studies (post-2010) (docetaxel anhydrous)	Studies (acetyl-11-ketoboswellic acid)	Trials (acetyl-11-ketoboswellic acid)	Recent Studies (post-2010) (acetyl-11-ketoboswellic acid)
12,110	3,216	6,920	137	2	98

Protein Interaction Comparison

Protein	Taxonomy	acetyl-11-ketoboswellic acid (IC50)
Prostaglandin E synthase	Homo sapiens (human)	3
Polyunsaturated fatty acid 5-lipoxygenase	Homo sapiens (human)	2.7
Prolyl endopeptidase	Homo sapiens (human)	7.89

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Banala, VT; Gayen, JR; Jajoriya, AK; Mishra, DP; Mishra, PR; Mitra, K; Mittapelly, N; Pandey, G; Sharma, S; Shukla, RP; Urandur, S; Valicherla, GR	1
Guo, YX; Kong, F; Lin, ZM; Liu, YQ; Lou, HX; Sun, DQ; Wang, Q; Wang, RM; Wang, SK; Xu, QQ; Yuan, HQ	1

Other Studies

2 other study(ies) available for docetaxel anhydrous and acetyl-11-ketoboswellic acid

Article	Year
P-gp modulatory acetyl-11-keto-β-boswellic acid based nanoemulsified carrier system for augmented oral chemotherapy of docetaxel. Colloids and surfaces. B, Biointerfaces, 2017, Jul-01, Volume: 155 Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Cell Line, Tumor; Docetaxel; Drug Carriers; Drug Compounding; Emulsions; Female; Frankincense; G2 Phase Cell Cycle Checkpoints; Humans; Mice; Mice, Inbred BALB C; Particle Size; Plant Oils; Taxoids; Triterpenes	2017
Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties. Acta pharmacologica Sinica, 2019, Volume: 40, Issue:5 Topics: Animals; Apoptosis; Cell Line, Tumor; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Inbred C57BL; Neoplastic Stem Cells; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; STAT3 Transcription Factor; Triterpenes	2019

Article

Year

P-gp modulatory acetyl-11-keto-β-boswellic acid based nanoemulsified carrier system for augmented oral chemotherapy of docetaxel.

Colloids and surfaces. B, Biointerfaces, 2017, Jul-01, Volume: 155

Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Cell Line, Tumor; Docetaxel; Drug Carriers; Drug Compounding; Emulsions; Female; Frankincense; G2 Phase Cell Cycle Checkpoints; Humans; Mice; Mice, Inbred BALB C; Particle Size; Plant Oils; Taxoids; Triterpenes

2017

Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties.

Acta pharmacologica Sinica, 2019, Volume: 40, Issue:5

Topics: Animals; Apoptosis; Cell Line, Tumor; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Inbred C57BL; Neoplastic Stem Cells; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; STAT3 Transcription Factor; Triterpenes

2019